Helen Boudreau

Helen Marie Boudreau currently works at Shattuck Labs, Inc., as Independent Director from 2020, Rallybio LLC, as Director from 2020, Field Trip Health, Inc., as Director, Rallybio Corp., as Independent Director from 2020, and Estuary Ventures LLC, as Managing Director.
Ms. Boudreau also formerly worked at Yum! Brands, Inc., as Director-Strategic Planning from 1996 to 1999, Evaxion AS, as Independent Director from 2020 to 2021, Field Trip Health Ltd., as Independent Director, Reunion Neuroscience, Inc., as Independent Director from 2020 to 2023, Premier, Inc., as Independent Director from 2020 to 2025, Field Trip Psychedelics, Inc., as Director, CARA Therapeutics, Inc., as Independent Director, Bank of America Corp., as Principal, Pfizer Inc., as Vice President-Finance, Research & Development, Novartis Oncology, Inc., as Chief Financial Officer & VP-Investor Relations from 2008 to 2012, Novartis Corp., as Chief Financial Officer from 2008 to 2014, McKinsey & Co., Inc., as Manager-Engagement from 1993 to 1996, Proteostasis Therapeutics, Inc., as Treasurer, Chief Financial & Accounting Officer from 2017 to 2018, Bill & Melinda Gates Medical Research Institute, as Chief Operating Officer from 2018 to 2019, and Forma Therapeutics, Inc., as Chief Financial Officer from 2014 to 2017.
Ms. Boudreau received her undergraduate degree in 1987 from the University of Maryland and Masters Business Admin degree in 1993 from the University of Virginia Darden School of Business.